Negative Psychosis Prevention Trials

Affiliations

Comment

Denise Lin. JAMA Psychiatry. 2017.

. 2017 Jun 1;74(6):651-652.

doi: 10.1001/jamapsychiatry.2017.0187.

No abstract available

Comment in

Negative Psychosis Prevention Trials-Reply.
McGorry PD, Nelson B, Amminger P. McGorry PD, et al. JAMA Psychiatry. 2017 Jun 1;74(6):652-653. doi: 10.1001/jamapsychiatry.2017.0184. JAMA Psychiatry. 2017. PMID: 28403452 No abstract available.

Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial.
McGorry PD, Nelson B, Markulev C, Yuen HP, Schäfer MR, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EY, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, Amminger GP. McGorry PD, et al. JAMA Psychiatry. 2017 Jan 1;74(1):19-27. doi: 10.1001/jamapsychiatry.2016.2902. JAMA Psychiatry. 2017. PMID: 27893018 Clinical Trial.